ArticleCancers2026
VITA Accelerator Neutron Sources: Status and Research Results.
Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
purposeTo develop an accelerator neutron source suitable for boron neutron capture therapy-a new promising method for treating malignant tumors-and to develop dosimetry tools and methods.
methodsResearch into the transport and acceleration of a beam of charged particles, development and manufacture of an accelerator neutron source, study of the radiation generated, and development and implementation of dosimetry tools and methods.
resultsA facility called VITA has been created, which includes a tandem electrostatic accelerator of an original design for producing a 2.3 MeV 10 mA proton beam, a lithium target for generating neutrons in the
conclusionsThe authors strongly recommend using prompt γ-ray spectroscopy in treatment and developing lithium neutron capture therapy, including in combination with BNCT, and note the high efficiency, reliability and compactness of the VITA
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.